A 12-week randomized, participant-and investigator-blinded, placebo-controlled, parallel group study to explore the efficacy, pharmacodynamics, safety, and pharmacokinetics of two doses of inhaled CSJ117 in adults with Chronic Obstructive Pulmonary Disease (COPD) - Trial PHRR211202-004106

Access comprehensive clinical trial information for PHRR211202-004106 through Pure Global AI's free database. This Phase 2 trial is sponsored by Novartis Healthcare Philippines, Inc. and is currently Terminated. The study focuses on Chronic Obstructive Pulmonary Disease (COPD).

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.